Dark

DYN
Dyne Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Dec 31, 2025 3:59:57 PM EST

19.55USD+1.823%(+0.35)1,433,842

0.00Bid 0.00Ask 0.00Spread

Pre-market

Dec 30, 2025 9:19:30 AM EST

19.69USD+2.552%(+0.49)0

After-hours

Dec 31, 2025 4:04:30 PM EST

19.56USD+0.051%(+0.01)8,322

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

3.22B

Headquarters

Waltham, MA, USA

Industry

Biotechnology

Next Earnings

Feb 26, 2026 (55d)

AES CNP NRG ALE XLU

DYN Stats

Avg. Vol. 10 Day

1,816,683

Avg. Vol. 30 Day

2,889,950

Employees

2,489

Market Cap

3,220,597,736

Shares Out.

164,652,236

On/Off Exchange

59%/41%

6 Month Beta

2.43

1 Year Beta

1.70

2 Year Beta

1.66

3 Year Beta

1.65

52 Week Low

6.36

52 Week High

26.22

SMA50

20.16

SMA200

13.71

1 Week

-2.40%

1 Month

-5.10%

3 Month

+56.48%

6 Month

+125.35%

1 Year

-23.17%

2 Year

+49.77%

5 Year

-6.86%

Profile

dyne therapeutics, inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the united states. it develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its force platform that delivers disease-modifying therapies. the company was founded in 2017 and is based in waltham, massachusetts.

DYN Stock Summary

Dyne Therapeutics, Inc. Common Stock (NASDAQ:DYN) stock price today is $19.55, and today's volume is 1,433,842. DYN is up 1.823% today. The 30 day average volume is 2,889,950. DYN market cap is 3.22B with 164,652,236 shares outstanding.